Houston, TX, United States of America

Bryan A Fisk

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Immunotherapy by Bryan A Fisk

Introduction

Bryan A Fisk is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of immunotherapy, particularly in the stimulation of T-lymphocytes. His work focuses on developing methods and compositions that enhance immune responses against specific cancer-related epitopes.

Latest Patents

Bryan A Fisk holds a patent for "Methods and compositions for stimulating T-lymphocytes." This patent discloses various methods, compositions, antibodies, and therapeutic kits designed to stimulate cytotoxic T-lymphocytes. The invention aims to generate immune responses against epitopes of protooncogenes. The novel peptides described in the patent have been shown to effectively stimulate cytotoxic T-lymphocytes and act as antigens in the generation of antibodies that recognize oncogenic epitopes. Additionally, the patent outlines methods for treating various proliferative disorders and diagnosing HER-2/neu-containing cells. Therapeutic kits useful in cancer treatment and the production of potential anti-cancer vaccines are also included in this patent.

Career Highlights

Bryan A Fisk is affiliated with the University of Texas System, where he continues to advance research in immunotherapy. His innovative work has the potential to impact cancer treatment significantly.

Collaborations

Some of his notable coworkers include Constantin G Ioannides and Maria G Ioannides. Their collaborative efforts contribute to the ongoing research and development in the field of immunotherapy.

Conclusion

Bryan A Fisk's contributions to immunotherapy through his patent on T-lymphocyte stimulation represent a significant advancement in cancer treatment. His work at the University of Texas System continues to pave the way for innovative therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…